MAP2K7 and melanoma: Supplementary to these previous findings, our study found that elevated POU4F1 could activate MEK/ERK that is a key link in the whole MAPK pathway, thus leading to the resistance to BRAFi in melanoma cells, which is a novel mechanism for MAPK pathway reactivation in melanoma under BRAFi treatment.